Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.52 |
| ▸ | CTSS | P25774 | 6/20 | 0.51 |
| ▸ | CTSK | P43235 | 6/20 | 0.51 |
| ▸ | PPARA | Q07869 | 6/20 | 0.49 |
| ▸ | PPARG | P37231 | 5/20 | 0.49 |
| ▸ | CTSL | P07711 | 1/20 | 0.49 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL47290 | 1.00 | TGFBR1 (0.52) | TGFBR1CTSSCTSKPPARAPPARG | |
| SCHEMBL315980 | 1.00 | TGFBR1 (0.52) | TGFBR1CTSSCTSKPPARAPPARG | |
| Water SCHEMBL23833041 | 0.98 | CTSS (0.54) | TGFBR1CTSSCTSKPPARAPPARG | |
| Ammonia Solution, Strong SCHEMBL28315164 | 0.98 | CTSK (0.50) | TGFBR1CTSSCTSKPPARAPPARG | |
| Water SCHEMBL31557653 | 0.98 | CTSS (0.54) | TGFBR1CTSSCTSKPPARAPPARG | |
| Propene SCHEMBL3265526 | 0.92 | CTSK (0.46) | TGFBR1CTSSCTSKPPARAPPARG | |
| SCHEMBL12980339 | 0.89 | CTSK (0.61) | TGFBR1CTSSCTSKPPARAPPARG | |
| SCHEMBL12980341 | 0.89 | CTSK (0.61) | TGFBR1CTSSCTSKPPARAPPARG | |
| Valine SCHEMBL5916993 | 0.87 | CA1 (0.45) | TGFBR1CTSSCTSKPPARAPPARG | |
| SCHEMBL29414393 | 0.87 | CTSS (0.46) | TGFBR1CTSSCTSKPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058547-A | Method for preparing lacosamide | 湖北葛店人福药业有限责任公司 | 2025-05-30 | — | — | CN | claimed |
| CN-118812395-A | Method for synthesizing lacosamide intermediate | 浙江普洛家园药业有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-115198386-B | Microporous pure protein fiber and preparation method thereof | 邦特云纤(青岛)新材料科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-116041441-A | Synthesis method of daptomycin | 申联生物医药（上海）股份有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-218530097-U | BOC-D-serine preparation filter equipment | 江苏吉泰肽业科技有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-115198386-A | Microporous pure protein fiber and preparation method thereof | 邦特云纤(青岛)新材料科技有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-114685317-A | Preparation method of medicine for treating epilepsy | 成都硕德药业有限公司 | 2022-07-01 | — | — | CN | claimed |
| EP-2444390-B1 | Process for producing Lacosamide | EUTICALS GMBH (DE) | 2017-02-01 | — | — | EP | claimed |
| US-8598386-B2 | Process for producing lacosamide | EUTICALS GMBH (DE) | 2013-12-03 | — | — | US | claimed |
| CN-101928230-B | Improved synthesis scheme for lacosamide | UCB PHARMA GMBH | 2012-11-07 | — | — | CN | claimed |
| EP-2444390-A1 | Process for producing Lacosamide | Archimica GmbH (DE) | 2012-04-25 | — | — | EP | claimed |
| US-20120095251-A1 | Process for Producing Lacosamide | EUTICALS GMBH (DE) | 2012-04-19 | — | — | US | claimed |
| CN-1989102-B | Improved lacosamide synthesis method | UCB PHARMA GMBH | 2011-04-20 | — | — | CN | claimed |
| CN-101928230-A | The synthetic method of improved scheme for lacosamide | UCB PHARMA SA | 2010-12-29 | — | — | CN | claimed |
| US-20260091024-A1 | PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE | BIOHAVEN THERAPEUTICS LTD (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4426683-B1 | BENZODIAZEPINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE GABA A GAMMA1 RECEPTOR | HOFFMANN LA ROCHE (CH) | 2026-04-01 | — | — | EP | disclosed |
| US-20260070912-A1 | BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM | HOFFMANN-LA ROCHE INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-4338437-A | Cephalosporin antibiotics | MERCK & CO., INC. (US) | 1982-07-06 | — | — | US | disclosed |
| US-4324890-A | ANTIBIOTICS, BACTERICIDES | MERCK & CO., INC. (US) | 1982-04-13 | — | — | US | disclosed |
| EP-0022621-A1 | Peptides related to somatostatin, their preparation and pharmaceutical compositions containing them | ELI LILLY AND COMPANY (US) | 1981-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091024-A1 | PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE | IL6ST, GFRA3, GFRA1 | TGFBR1 566/4885CTSS 1265/4885CTSK 1499/4885 |
| US-20120095251-A1 | Process for Producing Lacosamide | NAAA, TET3, GNMT | TGFBR1 4226/4885CTSS 2498/4885CTSK 2733/4885 |
| US-20260070912-A1 | BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM | GABRA1, GABRB1, GABRA6 | TGFBR1 1500/4885CTSS 4402/4885CTSK 4004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.